Table 1—

Patient demographics and study outcome

Patient demographicsCGMSCGMS/KADIS
n2524
Sex (female/male)13/129/15
Age (years)48.4 ± 15.549.8 ± 11.3
Diabetes duration (years)13.4 ± 11.115.1 ± 10.0
BMI (kg/m2)28.5 ± 7.331.6 ± 6.4
Diabetes type (1/2)14/1112/12
Diabetes specialist/general practitioner20/520/4
Outcome parameterBeforeAfterBeforeAfter
ΔA1C (%)*0.27 (−0.02 to 0.55)−0.34 (−0.56 to −0.12)
    A1Ct0< 7.0%0.24 ± 0.640.03 ± 0.42
    A1Ct0 7.0–8.0%0.74 ± 0.81−0.23 ± 0.36
    A1Ct0> 8.0%−0.12 ± 0.36−0.77 ± 0.55
A1C (%)7.18 ± 1.427.44 ± 1.507.75 ± 1.217.41 ± 1.07
Mean sensor glucose (mmol/l)7.75 ± 1.338.45 ± 2.468.43 ± 1.337.59 ± 1.47§
Hyperglycemia (h/day)3.2 (0.4–6.0)3.5 (1.0–9.0)§4.6 (1.8–8.3)1.0 (0.0–3.5)
Hypoglycemia (h/day)0.0 (0.0–0.1)0.0 (0.0–0.0)0.0 (0.0–0.0)0.0 (0.0–0.0)
BU11.8 ± 4.412.9 ± 5.312.6 ± 3.812.6 ± 3.9
Insulin (IU)50.5 (35–66)54 (33–71)53 (37–77)48 (35–72)
  • Data are means ± SD, mean (95% CI), or median (interquartile range). The euglycemic glucose range is defined as 4.4–8.9 mmol/l. Study subjects were classified according their baseline A1C (A1Ct0) into the groups <7% (n = 17), 7–8% (n = 18), and >8% (n = 11).

  • *

    * Mean (95% CI).

  • P < 0.01 vs. CGMS.

  • P < 0.01

  • §

    § P < 0.05 vs. before.

  • Mean (interquartile range).

  • P < 0.05 vs. CGMS.